Dr. Melvyn Rubenfire, professor of internal medicine and director of preventive cardiology at the University of Michigan Medical School, discusses recent findings that indicate statins may protect against cognitive deterioration among patients at high risk of dementia. How big an impact could be made by cholesterol-lowering drugs? Could we eventually incorporate statins into treatment patterns for dementia, and if so, what will it take to get us to this point? Dr. Larry Kaskel hosts.
Brought to you by: